Smith Nephew supplier risk profile Q1 2026: 67 shipments, 11 suppliers, China-dominant sourcing.
Smith Nephew imported 67 shipments across 11 suppliers in Q1 2026, sourcing from five countries. China dominated the footprint with 42 shipments (62.7% share), followed by India with 11 shipments. The top supplier, Smith Nephew Medical Suzhou Ltd., accounted for 27 shipments from China. Medical devices (HS Chapter 30) made up the largest product category, representing the core import profile.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
One name in Smith Nephew's supplier network matched a sanctions watchlist during the period. No suppliers registered exposure under the Uyghur Forced Labor Prevention Act framework.
11 distinct tier-1 suppliers in Q1 2026
| SMITH NEPHEW MEDICAL SUZHOU LIM | China | 27 |
| ENCUBE ETHICALS | India | 11 |
| T J SMITH NEPHEW | United Kingdom | 8 |
| STERIGENICS SHANGHAI ETO | China | 8 |
| ARTHROCARE COSTA RICA SRL | Costa Rica | 3 |
| SHANGHAI ISO MEDICAL PRODUCTS LT | China | 2 |
| MAPLE TREE MEDICAL DEVICES | China | 2 |
| TJ SMITH AND NEPHEW ALLOGA | United Kingdom | 2 |
Share of Q1 2026 inbound shipments by source country
12 tier-2 + 24 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.